tirzepatide weight loss compared to semaglutide vs for Treatment semaglutide tirzepatide weight loss comparison
Description
Tirzepatide, a new era of dual-targeted treatment for diabetes and obesity: A mini-review
Inspect the area
Not for human consumption, medical, veterinary, or diagnostic use
The reason for this name is because Tirzepatide targets both GLP-1 (glucagon-like peptide-1) and GIP (gastric inhibitory polypeptide) receptors in the body
Key findings from the SURMOUNT studies include: In SURMOUNT-1, participants on the highest dose of Zepbound (15 mg) lost 21% of their body weight (about 52 pounds) from an average starting weight of 231 pounds
Both contain tirzepatide
